Logo image of CMIL.CA

CAPELLA MINERALS LTD (CMIL.CA) Stock Fundamental Analysis

TSX-V:CMIL - TSX Venture Exchange - CA13960M1023 - Common Stock - Currency: CAD

0.04  0 (0%)

Fundamental Rating

0

Overall CMIL gets a fundamental rating of 0 out of 10. We evaluated CMIL against 822 industry peers in the Metals & Mining industry. CMIL has a bad profitability rating. Also its financial health evaluation is rather negative. CMIL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year CMIL has reported negative net income.
In the past year CMIL has reported a negative cash flow from operations.
In the past 5 years CMIL reported 4 times negative net income.
In the past 5 years CMIL always reported negative operating cash flow.
CMIL.CA Yearly Net Income VS EBIT VS OCF VS FCFCMIL.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M

1.2 Ratios

CMIL has a Return On Assets of -320.63%. This is amonst the worse of the industry: CMIL underperforms 82.67% of its industry peers.
Looking at the Return On Equity, with a value of -1438.29%, CMIL is doing worse than 75.88% of the companies in the same industry.
Industry RankSector Rank
ROA -320.63%
ROE -1438.29%
ROIC N/A
ROA(3y)-109.34%
ROA(5y)-130.23%
ROE(3y)-328.01%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CMIL.CA Yearly ROA, ROE, ROICCMIL.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600 -800

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CMIL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CMIL.CA Yearly Profit, Operating, Gross MarginsCMIL.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

1

2. Health

2.1 Basic Checks

CMIL has more shares outstanding than it did 1 year ago.
CMIL has less shares outstanding than it did 5 years ago.
The debt/assets ratio for CMIL is higher compared to a year ago.
CMIL.CA Yearly Shares OutstandingCMIL.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CMIL.CA Yearly Total Debt VS Total AssetsCMIL.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

Based on the Altman-Z score of -20.51, we must say that CMIL is in the distress zone and has some risk of bankruptcy.
CMIL has a worse Altman-Z score (-20.51) than 74.67% of its industry peers.
A Debt/Equity ratio of 0.60 indicates that CMIL is somewhat dependend on debt financing.
CMIL has a worse Debt to Equity ratio (0.60) than 72.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF N/A
Altman-Z -20.51
ROIC/WACCN/A
WACCN/A
CMIL.CA Yearly LT Debt VS Equity VS FCFCMIL.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M

2.3 Liquidity

A Current Ratio of 0.08 indicates that CMIL may have some problems paying its short term obligations.
CMIL's Current ratio of 0.08 is on the low side compared to the rest of the industry. CMIL is outperformed by 81.33% of its industry peers.
CMIL has a Quick Ratio of 0.08. This is a bad value and indicates that CMIL is not financially healthy enough and could expect problems in meeting its short term obligations.
CMIL's Quick ratio of 0.08 is on the low side compared to the rest of the industry. CMIL is outperformed by 81.21% of its industry peers.
Industry RankSector Rank
Current Ratio 0.08
Quick Ratio 0.08
CMIL.CA Yearly Current Assets VS Current LiabilitesCMIL.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M

0

3. Growth

3.1 Past

The earnings per share for CMIL have decreased strongly by -1798.46% in the last year.
EPS 1Y (TTM)-1798.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-407.14%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CMIL.CA Yearly Revenue VS EstimatesCMIL.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024
CMIL.CA Yearly EPS VS EstimatesCMIL.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CMIL. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CMIL.CA Price Earnings VS Forward Price EarningsCMIL.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CMIL.CA Per share dataCMIL.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.02 -0.04 -0.06 -0.08 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CMIL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CAPELLA MINERALS LTD

TSX-V:CMIL (3/6/2025, 7:00:00 PM)

0.04

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)01-27 2022-01-27
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners4.45%
Ins Owner ChangeN/A
Market Cap1.58M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.12
P/tB 4.12
EV/EBITDA N/A
EPS(TTM)-0.12
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -320.63%
ROE -1438.29%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-109.34%
ROA(5y)-130.23%
ROE(3y)-328.01%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.08
Quick Ratio 0.08
Altman-Z -20.51
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1798.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-407.14%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y18.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y49.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.24%
OCF growth 3YN/A
OCF growth 5YN/A